Article info
Neuroinfection
Research paper
Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS
- Correspondence to Dr Mike P Wattjes, Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Carl-Neuberg-Straße 1, D-30625 Hannover, Germany; wattjes.mike{at}mh-hannover.de
Citation
Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS
Publication history
- Received July 16, 2017
- Revised October 16, 2017
- Accepted October 19, 2017
- First published November 15, 2017.
Online issue publication
April 12, 2018
Article Versions
- Previous version (15 November 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.